第三代认知行为治疗与常规治疗用于注意缺陷多动障碍的多中心随机对照试验
本研究为多中心、随机(1:1)、2平行组、优势性试验,评估者盲法,按中心和哌甲酯治疗分层,计划纳入248名确诊ADHD儿童,比较基于第三代认知行为治疗的Hyper-mCBT项目与Barkley常规治疗项目对ADHD症状严重程度的改善;Hyper-mCBT包含16次家长与儿童同时但分开进行的治疗课程。
要点
- 研究比较Hyper-mCBT与Barkley项目对ADHD儿童症状严重程度的改善。
- Hyper-mCBT包含16次家长与儿童同时但分开进行的治疗课程。
- 试验为多中心随机优势性设计,评估者盲法,按中心和哌甲酯治疗分层。
核心结论
- 本试验将验证一种面向家长和儿童的创新心理治疗项目的初步 encouraging 结果。
研究设计与样本
- 多中心、随机(1:1)、2平行组、优势性试验,评估者盲法,按中心和哌甲酯治疗分层。
- 计划纳入248名确诊ADHD儿童,随机分配至Hyper-mCBT项目或Barkley项目。
关键数值与推荐
- Hyper-mCBT项目包含16次家长与儿童同时但分开进行的治疗课程。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to compare improvements in attention deficit and hyperactivity disorder (ADHD) symptom severity between a group of ADHD children and parents undergoing a new therapeutic program based on third-generation cognitive behavioral therapy (Hyper-mCBT) and a similar group undergoing treatment-as-usual with the Barkley program. METHODS: Two hundred forty-eight children diagnosed with ADHD will be randomly assigned to either a Hyper-mCBT program or a Barkley program. This is a multicenter randomized (1:1), 2 parallel-group, superiority trial with evaluator blinding and stratification according to center and methylphenidate treatment. The Hyper-mCBT program consists in a series of 16 simultaneous-but-separate therapy sessions for parents and for children. DISCUSSION: More effective psychotherapeutic approaches are needed for ADHD children. Pharmacotherapy seems to be more effective in reducing ADHD symptoms but it is not always helpful, it carries side effects, and it is rejected by many parents/professionals. Results for psychotherapy programs for ADHD are inconsistent although several studies have shown clinical improvements. This trial will substantiate encouraging preliminary results of an innovative psychotherapy program for both parents and children. TRIAL REGISTRATION: ClinicalTrials.gov NCT03437772 . Registered on February 19, 2018. Sponsor number: PHRC-N/2016/JLC-01. RCB identification: 2017-A01349-44.
引用
- Crouzet L, Gramond A, Suehs C, et al. Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial. Trials. 2022. PMID: 35090544. doi:10.1186/s13063-021-05983-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。